edoc

Items where contributor is "Ruhstaller, Thomas"

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2011 | 2009 | 2008

2011

Rochlitz, C. and Ruhstaller, T. and Lerch, S. and Spirig, C. and Huober, J. and Suter, T. and Buhlmann, M. and Fehr, M. and Schonenberger, A. and von Moos, R. and Winterhalder, R. and Rauch, D. and Muller, A. and Mannhart-Harms, M. and Herrmann, R. and Cliffe, B. and Mayer, M. and Zaman, K.. (2011) Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer : a multicenter, single-arm phase II trial (SAKK 24/06). Annals of oncology, Vol. 22, H. 1. S. 80-85.

Ruhstaller, Thomas and Pless, Miklos and Dietrich, Daniel and Kranzbuehler, Helmut and von Moos, Roger and Moosmann, Peter and Montemurro, Michael and Schneider, Paul M. and Rauch, Daniel and Gautschi, Oliver and Mingrone, Walter and Widmer, Lucas and Inauen, Roman and Brauchli, Peter and Hess, Viviane. (2011) Cetuximab in Combination With Chemoradiotherapy Before Surgery in Patients With Resectable, Locally Advanced Esophageal Carcinoma : a Prospective, Multicenter Phase IB/II Trial (SAKK 75/06). Journal of clinical oncology, Vol. 29, H. 6. S. 626-631.

Bolla, Daniele and Ruhstaller, Thomas and Diener, Pierre-André and Lang, Franziska and Hornung, Rène. (2011) Cervical and vaginal cancer in a woman with chronic graft-versus-host disease. International journal of gynecology & obstetrics, Vol. 114, H. 2. S. 159-160.

Koeberle, D. and Ruhstaller, T. and Jost, L. and Pagani, O. and Zaman, K. and von Moos, R. and Oehlschlegel, C. and Crowe, S. and Pilop, C. and Thuerlimann, B. and Swiss Grp Clinical Canc Res Sakk, . (2011) Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer : a proof-of-concept trial (SAKK 23/03). Endocrine related cancer, Vol. 18, H. 2. S. 257-264.

2009

Ruhstaller, T. and Widmer, L. and Schuller, J. C. and Roth, A. and Hess, V. and Mingrone, W. and von Moos, R. and Borner, M. and Pestalozzi, B. C. and Balmermajno, S. and Köberle, D. and Terraciano, L. and Schnider, A. and Bodis, S. and Popescu, R.. (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 20. S. 1522-1528.

Ruhstaller, Thomas and von Moos, Roger and Rufibach, Kaspar and Ribi, Karin and Glaus, Agnes and Spaeti, Bruno and Koeberle, Dieter and Mueller, Urs and Hoefliger, Markus and Hess, Dagmar and Boehme, Christel and Thuerlimann, Beat. (2009) Breast cancer patients on endocrine therapy reveal more symptoms when self-reporting than in pivotal trials: an outcome research study. Oncology : international journal of cancer research and treatment, Vol. 76. S. 142-148.

Klaeser, Bernd and Nitzsche, Egbert and Schuller, Jan C. and Köberle, Dieter and Widmer, Lucas and Balmer-Majno, Sabine and Hany, Thomas and Cescato-Wenger, Corinne and Brauchli, Peter and Zünd, Michael and Pestalozzi, Bernhard C. and Caspar, Clemens and Albrecht, Susanne and von Moos, Roger and Ruhstaller, Thomas. (2009) Limited predictive value of FDG-PET for response assessment in the preoperative treatment of esophageal cancer : results of a prospective multi-center trial (SAKK 75/02). Onkologie : Zeitschrift für Krebsforschung und -behandlung, Vol. 32. S. 724-730.

Spirig, Christian and Omlin, Aurelius and D'Addario, Giannicola and Loske, Klaus-Dieter and Esenwein, Philipp and Geismar, Jan Henning and Ruhstaller, Thomas. (2009) Radiation recall dermatitis with soft tissue necrosis following pemetrexed therapy : a case report. Journal of medical case reports, Vol. 3. S. 93.

2008

Hess, V. and Glimelius, B. and Grawe, P. and Dietrich, D. and Bodoky, G. and Ruhstaller, T. and Bajetta, E. and Saletti, P. and Figer, A. and Scheithauer, W. and Herrmann, R.. (2008) CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial. The Lancet oncology, Vol. 9. S. 132-138.

Grimm, Birgit and Padberg, Barbara and Ruhstaller, Thomas and Fleisch, Felix and von Moos, Roger. (2008) Fatal herpes simplex virus hepatitis in a patient with esophageal cancer under radiochemotherapy. Onkologie, Vol. 31. S. 620-622.

Bernhard, J. and Dietrich, D. and Scheithauer, W. and Gerber, D. and Bodoky, G. and Ruhstaller, T. and Glimelius, B. and Bajetta, E. and Schüller, J. and Saletti, P. and Bauer, J. and Figer, A. and Pestalozzi, B. C. and Köhne, C. H. and Mingrone, W. and Stemmer, S. M. and Tàmas, K. and Kornek, G. V. and Koeberle, D. and Herrmann, R. and Central, European Cooperative Oncology Group. (2008) Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone : a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology, Vol. 26. S. 3695-3701.

Koeberle, D. and Saletti, P. and Borner, M. and Gerber, D. and Dietrich, D. and Caspar, C. B. and Mingrone, W. and Beretta, K. and Strasser, F. and Ruhstaller, T. and Mora, O. and Herrmann, R. and Swiss, Group for Clinical Cancer Research. (2008) Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine : a multicenter, phase II trial of the swiss group for clinical cancer research. Journal of clinical oncology, Vol. 26. S. 3702-3708.

Borner, M. and Koeberle, D. and Von Moos, R. and Saletti, P. and Rauch, D. and Hess, V. and Trojan, A. and Helbling, D. and Pestalozzi, B. and Caspar, C. and Ruhstaller, T. and Roth, A. and Kappeler, A. and Dietrich, D. and Lanz, D. and Mingrone, W. and Swiss, Group for Clinical Cancer Research and Bern, and Switzerland, . (2008) Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer : a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK. Annals of oncology, Vol. 19, H. 7. S. 1288-1292.

Koeberle, D. and Burkhard, R. and von Moos, R. and Winterhalder, R. and Hess, V. and Heitzmann, F. and Ruhstaller, T. and Terraciano, L. and Neuweiler, J. and Bieri, G. and Rust, C. and Toepfer, M.. (2008) Phase II study of capecitabine and oxaliplatin given prior to and concurrently with preoperative pelvic radiotherapy in patients with locally advanced rectal cancer. British journal of cancer, Vol. 98, no. 7. S. 1204-1209.

Greuter, S. and Schmid, F. and Ruhstaller, T. and Thuerlimann, B.. (2008) Bevacizumab-associated osteonecrosis of the jaw. Annals of oncology, Vol. 19, H. 12. S. 2091-2092.